UroGen Pharma Ltd. (URGN) short interest & options flow
NASDAQShort sellers have been cutting exposure to URGN at a meaningful pace, with short interest falling 30% from its October highs even as the stock gives back some of this year's gains ahead of its November 10 earnings release. The unwinding has been rapid. Short interest peaked near 7.7 million shares in mid-October, representing roughly 16% of the free float. By November 3 it had…
URGN short interest falls 30% in one week to 11.3% of float, down from a peak of 7.7M shares on Oct 16. Availability surges to 735%, signaling easier stock to borrow as sellers unwind.
- Market cap
- $1.40B
- Next earnings
- 10 Nov 2026
Key data as of 5 Nov 2026
Latest signals on URGN
- Short Interest
URGN short interest falls 30% in one week to 11.3% of float, down from a peak of 7.7M shares on Oct 16. Availability surges to 735%, signaling easier stock to borrow as sellers unwind.
3 Short Interest updates in 30 days
URGN news and analysis
RSSNo long-form analysis yet for URGN. Pulse alerts and the live data picture are available on ORTEX.
Open URGN on ORTEX →Want the live picture for URGN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for URGN — free to start on ORTEX.
Sign up for free →Open URGN on ORTEX